
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[CYTK] Cytokinetics Inc - Shareholder Equity / Assets
Data updated 2023-Sep-02 (Saturday)Note: Detailed Statistics for Shareholder Equity / Assets in Balance Sheet for Cytokinetics Inc [NASDAQ:CYTK] with frequency distribution chart that analyze trends & history . Total Shareholder Equity / Total Assets is expressed as a %. View Balance Sheet for broader context
Share
Quarterly Shareholder Equity / Assets values for Cytokinetics Inc are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Shareholder Equity / Assets | -42.7% | -25.7% | -10.6% | -1.5% | 14.4% | 13.6% |
Sequential Quarter Growth | -66.0% | -141.8% | -614.1% | -110.4% | +6.1% | -53.3% |
Quarter-on Quarter Growth | -397.0% | -289.9% | -136.7% | -105.0% | +392.5% | +15.2% |
Annual Shareholder Equity / Assets values for Cytokinetics Inc are rounded to enhance readability
2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | 2017-Dec | |
---|---|---|---|---|---|---|
Shareholder Equity / Assets | -10.6% | 29.0% | 21.2% | -3.8% | 12.3% | 37.3% |
Year-on-Year Growth | -136.7% | +37.1% | +658.3% | -130.8% | -66.9% | |
2-yr CAGR | +31.1% | |||||
3-yr CAGR | +33.0% | -17.2% | ||||
4-yr CAGR | -6.1% | |||||
5-yr CAGR |
Frequency distribution of quarterly Shareholder Equity / Assets values from 2017-Dec-31 grouped into buckets. Latest Shareholder Equity / Assets value is -42.7 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Cytokinetics Inc mapped with quarterly Shareholder Equity / Assets values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Shareholder Equity / Assets above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Cytokinetics Inc with subsequent post-earnings performance given Shareholder Equity / Assets values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Shareholder Equity / Assets - Low | 63% | 38% |
Shareholder Equity / Assets - Medium | 14% | 86% |
Shareholder Equity / Assets - High | 71% | 29% |
Shareholder Equity / Assets (Sequential growth %) - Low | 29% | 71% |
Shareholder Equity / Assets (Sequential growth %) - Medium | 43% | 57% |
Shareholder Equity / Assets (Sequential growth %) - High | 71% | 29% |
Shareholder Equity / Assets (QoQ growth %) - Low | 17% | 83% |
Shareholder Equity / Assets (QoQ growth %) - Medium | 50% | 50% |
Shareholder Equity / Assets (QoQ growth %) - High | 50% | 50% |
Related to Cytokinetics Inc
Information for Cytokinetics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-10 on Google
SEC Reports : Quarterly reports around 2025-Jul-10 on SEC Edgar
Compare Cytokinetics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Cytokinetics Inc
Industry : Biotechnology industry performance which includes Cytokinetics Inc